CareStart COVID-19 IgM/IgG

Slide

CARESTART™

COVID-19
IgM/IgG


Rapid Diagnostic Test for the Detection of SARS-CoV-2 IgM/IgG Ab


ORDER NOW

Slide

CARESTART™

COVID-19
lgM/lgG


COVID-19 RAPID DETECTION KITS


ORDER NOW
ACCESS BIO’S CARESTART™ COVID-19 lgM/lgG

RAPID COVID-19 Testing TOOL

NOW FDA EMERGENCY USE AUTHORIZED

SARS-CoV-2, A highly contagious novel virus, had severely impacted the U.S. and global healthcare system and economy. A rapid in vitro testing is a key component to identify and mitigate the spread. The CareStart™ Covid 19 IgM/IgG Rapid Diagnostic Test for the Detection of SARS-CoV-2 IgM/IgG Ab provides a fast and easy diagnostic tool for COVID-19 in the limited testing environment.

  • Fast and easy to use in a qualified CLIA setting
  • Detect and differentiate IgM/IgG antibody specific to SARS-CoV-2.
  • Requires small sample volume (10 uL of venous whole blood, serum, or plasma).
  • Results available in 10 minutes.
  • No equipment or training required.
  • Identify and monitor individual’s previous infection history and immune response to COVID-19.
  • Clinical performance (NIH/NCI) of 100% sensitivity and 97.5% specificity.
  • CE certified.

TEST PRINCIPLES

The CareStart™ Covid 19 IgM/IgG Rapid Diagnostic Test for the Detection of SARS-CoV-2 IgM/IgG Ab is a lateral flow immunochromatographic assay which can differentiate SARS-CoV-2 Immunoglobin IgM and IgG antibodies in human blood specimens in a single test within 10 minutes.

Contact Us

Contact us to place an order.

Please provide your information, and we will contact you within one business day.

Sign Up to Receive News and Updates

We take your privacy seriously. Your information will
never be sold or shared with third-parties.

Translate »